Affine Formulations Limited

Pharmaceutical company manufacturing tablets, capsules, syrups, and other drugs in Indore, MP.

2006 | Indore, Madhya Pradesh (India) | Active
Last Updated: February 18, 2025

Affine Formulations Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 6.00 Cr
  • Company Age 18 Year, 7 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 13.39 Cr
  • Satisfied Charges ₹ 8.81 Cr
  • Revenue Growth 4.50%
  • Profit Growth -28.48%
  • Ebitda 0.72%
  • Net Worth 4.13%
  • Total Assets -15.74%

About Affine Formulations

Affine Formulations Limited (AFL) is a leading Public Limited Indian Non-Government Company incorporated in India on 04 July 2006 and has a history of 18 years and seven months. Its registered office is in Indore, Madhya Pradesh, India.

The Corporate was formerly known as Affine Formulations Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.00 Cr.

The company currently has active open charges totaling ₹13.39 Cr. The company has closed loans amounting to ₹8.81 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Affine Formulations Limited India is Anil Jain as CFO. Vijay Nyati, Pradhyumn Nyati, and Shailendra Biyani serve as directors at the Company.

Company Details

  • Location

    Indore, Madhya Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    affineformulations.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232MP2006PLC018755

  • Company No.

    018755

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    04 Jul 2006

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Gwalior

Industry

Pharma

Who are the key members and board of directors at Affine Formulations?

Executive Team (1)

NameDesignationAppointment DateStatus
Anil Jain CFOCurrent

Board Members (3)

NameDesignationAppointment DateStatus
Vijay Nyati Country flag representing In Director 04-Jul-2006Current
Pradhyumn Nyati Country flag representing In Director 15-Apr-2008Current
Shailendra Biyani Country flag representing In Director 15-Apr-2008Current

Financial Performance of Affine Formulations.

Affine Formulations Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.5% increase. The company also saw a substantial fall in profitability, with a 28.48% decrease in profit. The company's net worth moved up by a moderate rise of 4.13%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
4.50%
Revenue from Operations
4.68%
Total Assets
-15.74%
Profit or Loss
-28.48%
Net Worth
4.13%
EBITDA
0.72%

What is the Ownership and Shareholding Structure of Affine Formulations?

In 2022, Affine Formulations had a promoter holding of 32.43% and a public holding of 67.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹13.39 Cr

Satisfied Charges

₹8.81 Cr

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 13.39 Cr

Latest Charge Details

DateLenderAmountStatus
26 Sep 2018Axis Bank Limited₹13.39 CrOpen
07 Dec 2006State Bank Of India₹8.81 CrSatisfied

How Many Employees Work at Affine Formulations?

Affine Formulations has a workforce of 26 employees as of Feb 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Affine Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Affine Formulations's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Affine Formulations

Recent activity within the organization

  • Annual General Meeting

    Affine Formulations Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

    30 Sep 2022

  • Balance Sheet

    Affine Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Gwalior.

    31 Mar 2022

  • Charges

    A charge with Axis Bank Limited of Rs. 13.39 Cr registered on 26 Sep 2018 with Charge ID 100219357 was modified on 08 Feb 2022.

    08 Feb 2022

  • Charges

    A charge registered on 07 Dec 2006 via Charge ID 10033474 with State Bank Of India was fully satisfied on 18 Jan 2019.

    18 Jan 2019

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 13.39 Cr with Charge ID 100219357 was registered on 26 Sep 2018.

    26 Sep 2018

  • Charges

    A charge with State Bank Of India of Rs. 8.81 Cr registered on 07 Dec 2006 with Charge ID 10033474 was modified on 07 Apr 2012.

    07 Apr 2012

Frequently asked questions

  • Affine Formulations Limited was incorporated on 04 Jul 2006.

  • The authorized share capital of Affine Formulations Limited is ₹ 10.00 Cr and paid-up capital is ₹ 6.00 Cr.

  • Currently 4 directors are associated with Affine Formulations Limited.

    • Vijay Kumar Nyati
    • Pradhyumn Nyati
    • Shailendra Biyani
    • Anil Kumar Jain
  • As per Ministry of Corporate Affairs (Mca), the registered address of Affine Formulations Limited is 28/10 Talwali Dewas Naka India, Indore, Madhya Pradesh, 452010.

  • The corporate identification number (CIN) of Affine Formulations Limited is U24232MP2006PLC018755 and the company number is 018755 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Affine Formulations Limited is https://www.affineformulations.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Affine Formulations Limited has risen by 4.50%.

  • As Per 2022 financial reports, 26 employees are currently employed by Affine Formulations Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Affine Formulations Limited has experienced an upsurge of 4.13%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Affine Formulations Limited amount to ₹ 13.39 Cr.

  • The most recent Balance Sheet for Affine Formulations Limited was filed with the ROC on 31 Mar 2022.

People also Viewed

Similar Companies Based on Drug Formulation & Development